STANLIB is a specialist investment manager, administering over R600 billion in assets under management.
Whether you need to preserve your capital or create wealth in the long term, our teams of investment specialists can help you achieve your goals. We offer a depth of expertise across investment disciplines – from absolute return and fixed income to listed property, balanced, equity and alternatives; spanning active and passive management, single and multi-manager offerings.
Through this wide range of investment capabilities we offer our clients both pooled and segregated investment solutions across a broad choice of traditional and alternative asset classes.
With our clients at the centre, our investment teams are developed to deliver outstanding outcomes through the skill, passion and dedication of each team member. Their unique blend of skills, areas of specialisation and perspectives enables us to make better-informed decisions so we can help our clients, both individuals and institutions, achieve their financial goals.
Combined with our teams’ range of specialist skills, their focus on in-depth research and risk mitigation strategies, examining markets from diverse perspectives culminates in consistent long-term investment performance.
We are proud of our South African heritage and the legacies of our founders. The size of our organisation allows for the acquisition of advanced systems, databases and research facilities and provides unique investment opportunities while our specialist team structure enables distinct focus on their areas of expertise.
STANLIB Asset Management is an authorised financial services provider.
Single-manager investments, Multi-manager investments, and Index and quantitative investments
Intelligent investingOur strategic partnership with J.P. Morgan Asset Management gives your money access to more growth potential. Invest to gain access to opportunities across broader markets, and leverage the depth of expertise, access to a global research team and a proven long-term track record these teams of investment professionals offer.Learn MoreInvest with cautionVerify the identity
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 2 Oct 2014 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 10 Nov 2017 | |